- Home
- AVIR vs WSBF Comparison
AVIR vs WSBF Comparison
Compare AVIR & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- WSBF
- Stock Information
- Founded
- AVIR 2012
- WSBF 1921
- Country
- AVIR United States
- WSBF United States
- Employees
- AVIR N/A
- WSBF N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- WSBF Savings Institutions
- Sector
- AVIR Health Care
- WSBF Finance
- Exchange
- AVIR Nasdaq
- WSBF Nasdaq
- Market Cap
- AVIR 251.7M
- WSBF 269.9M
- IPO Year
- AVIR 2020
- WSBF N/A
- Fundamental
- Price
- AVIR $3.09
- WSBF $14.19
- Analyst Decision
- AVIR Hold
- WSBF
- Analyst Count
- AVIR 1
- WSBF 0
- Target Price
- AVIR $6.88
- WSBF N/A
- AVG Volume (30 Days)
- AVIR 318.0K
- WSBF 52.5K
- Earning Date
- AVIR 03-03-2025
- WSBF 01-28-2025
- Dividend Yield
- AVIR N/A
- WSBF 4.21%
- EPS Growth
- AVIR N/A
- WSBF 118.94
- EPS
- AVIR N/A
- WSBF 1.01
- Revenue
- AVIR N/A
- WSBF $135,638,000.00
- Revenue This Year
- AVIR N/A
- WSBF N/A
- Revenue Next Year
- AVIR N/A
- WSBF N/A
- P/E Ratio
- AVIR N/A
- WSBF $14.41
- Revenue Growth
- AVIR N/A
- WSBF 3.74
- 52 Week Low
- AVIR $2.75
- WSBF $10.60
- 52 Week High
- AVIR $4.60
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- AVIR 48.26
- WSBF 54.08
- Support Level
- AVIR $3.04
- WSBF $13.38
- Resistance Level
- AVIR $3.25
- WSBF $14.83
- Average True Range (ATR)
- AVIR 0.13
- WSBF 0.40
- MACD
- AVIR 0.01
- WSBF 0.07
- Stochastic Oscillator
- AVIR 54.29
- WSBF 50.03
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.